Lu177-PSMA therapy for men with advanced prostate cancer: Initial 18 months experience at a single Australian tertiary institution. [electronic resource]
- Journal of medical imaging and radiation oncology Aug 2019
- 538-545 p. digital
Publication Type: Journal Article
1754-9485
10.1111/1754-9485.12891 doi
Aged Aged, 80 and over Australia Follow-Up Studies Humans Lutetium--therapeutic use Male Middle Aged Prostate-Specific Antigen--blood Prostatic Neoplasms, Castration-Resistant--blood Radioisotopes--therapeutic use Tertiary Care Centers Treatment Outcome